Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia Pharmaceuticals

▴ Sesderma Founder and renowned Spanish dermatologist Professor Dr. Gabriel Serrano
The exclusive dermo-focused symposiums will feature the latest advances in regenerative dermatology, nanotechnology, and science-backed skincare.

New Delhi, August 10, 2026: Sesderma Founder and renowned Spanish dermatologist Professor Dr. Gabriel Serrano is visiting India to participate in exclusive scientific symposiums hosted by Iberia Pharmaceuticals. The symposiums, scheduled to take place in New Delhi and Hyderabad, will bring together the country's dermatology community for meaningful discussions and an exchange of scientific knowledge and insights.

The ‘Grand Dermatology Symposiums’ will bring together pharma skincare industry stakeholders including leading dermatologists, and key opinion leaders to explore the latest advancements in dermatological science and innovation. At the symposiums, Professor Dr. Gabriel Serrano will share insights into the regenerative dermatology, nanotechnology-based dermo-cosmetics, micro-needling technologies, skin longevity, healthy skin ageing and chemical peels tailored to the Indian skin photo types. The symposiums will focus on key global advancements in:

Professor Dr. Gabriel Serrano will discuss emerging approaches to skin and body regeneration, including the growing role of regenerative medicine in skincare. He will also highlight innovative technologies and devices designed to enable more precise and effective skin treatments. Explaining the advanced skin peels, he will share his insights how they are developed to address the specific needs of Indian skin.

Widely known for being the pioneer in the application of nanotechnology in dermatology and for developing specialized skincare and cosmetic solutions, Professor Dr. Gabriel Serrano brings decades of expertise to these discussions. He holds several patents in anti-ageing skincare, chemical peels and sun-damage repair. He founded Sesderma with a vision to provide advance personalized, high-quality dermo-cosmetic solutions through research and innovation. Currently, he focuses on expanding Sesderma’s presence internationally, with the brand now available in more than 80 countries.

Speaking on his upcoming visit to India, Professor Dr. Gabriel Serrano says “I have always been committed to innovation and research, and I firmly believe that continuing to develop effective products and treatments is the only way to deliver the best. India’s dynamic skin profiles with growing demand for science-backed skincare makes for an exciting chapter ahead. The symposiums will provide an inspiring opportunity to collaborate with the dermatologist communities in India. I look forward to engaging with India’s medical community and sharing the latest developments in regenerative medicine, nanotechnology, and personalized skincare.”

As India's dermatology and dermo- cosmetic sector is experiencing positive and a welcome shift towards evidence-based, and science-backed solutions for skincare, Sesderma, a global dermatology company, is growing its presence in India through increased engagement with India’s dermatology community, and continued investments in research & innovations for the Indian skin.

On the partnership with Sesderma, Mr. Nitin Jain, Founder and Managing Director, Iberia Pharmaceuticals, says, “The Indian youth is increasingly seeking skin care products backed by science-based formulations, and we at Iberia firmly believe that bringing world-class skincare solutions to India is key to this new wave of demand. Our partnership with Sesderma is built on a shared commitment to scientific excellence, innovation, and delivering advanced derma-tech in India.”

Iberia Pharmaceuticals being the official and exclusive partner for Sesderma in India, plays a significant role in boosting the brand’s growth in the country, and with its strong penetration in dermatology ecosystem, the market knowledge, and nationwide distribution capabilities, the company is leading the expansion of Sesderma across evolving markets including the Tier-II cities in India.

Commenting on the symposiums, Mr. Saurav Ojha, Co-Founder & Whole-Time Director at Iberia Pharmaceuticals says “At Iberia Pharmaceuticals, our aim has primarily been to bring the best of global dermatological science-backed skincare to India that addresses the unique needs of the Indian skin. The symposiums hosted by us for the celebrated Professor Dr. Gabriel Serrano provides a powerful knowledge exchange platform to India’s dermatological community.”

India’s increasing demand for science backed skincare, and deeper adoption of clinically certified dermo-cosmetic solutions, we are expanding our footprint beyond metropolitan markets to Tier-II cities, making advanced skincare innovations more accessible to people nationwide.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026
How Can Diabetes and High Blood Pressure Quietly Lead to Kidney Failure?September 30, 2026
Apollo Hospitals’ “My Hands Are Ready” Sets World Record Title with 61,221 CPR Pledges in 30 DaysSeptember 30, 2026
How Medical Device Trials and Validation Shape Safer Healthcare Innovation in IndiaSeptember 30, 2026
Medical Device Safety in India: What Patients Should Know About Recalls and AlertsSeptember 30, 2026
Smart Implants: How Connected Devices Could Transform Follow-Up Care in IndiaSeptember 30, 2026
Single-Use Medical Devices: Innovation, Cost and Sustainability in Indian HealthcareSeptember 30, 2026
11th National Convention on Medicine & Law 2026 Successfully Concludes at D Y Patil University, Navi MumbaiSeptember 29, 2026
Can Your Skin Show the Signs of Chronic Stress? Dermatologists Explain What to Watch ForSeptember 29, 2026
MDI Gurgaon’s Samvaad X ScaNxt NXT STEP to Put Strategic Decision-Making Under Polycrisis Conditions to TestSeptember 29, 2026
Point-of-Care Diagnostics in India: Bringing Faster Testing Closer to PatientsSeptember 29, 2026
Adult Vaccination in India: The Preventive Care Gap Beyond ChildhoodSeptember 29, 2026
Maternal Nutrition Beyond Iron and Folic Acid: What Modern Prenatal Care in India Should IncludeSeptember 29, 2026